{'fraction_non_alphanumeric': 0.02786377708978328, 'fraction_numerical': 0.01393188854489164, 'mean_word_length': 5.338235294117647, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Colorimetric identification of miRNA‐195 sequence for diagnosing osteosarcoma

Improving biosensing performance is mandatory for biomolecular recognition and disease identification. Gold nanoparticle (GNP)‐based colorimetric assay is the easy and cost‐effective identification method by a naked eye detection. In this research, osteosarcoma biomarker (miRNA‐195) was identified by citrate‐capped GNP‐colorimetric assay. As salt‐induced aggregation was used to observe the color changes of GNP, sodium chloride (NaCl) and capture DNA were optimized as 50 mM and ∼20 pmol, respectively. The capture DNA only on GNP could not stabilize under high NaCl, and the color of GNP turned into purple. At the same time, when capture DNA was hybridized with target, the condition can stabilize the GNP under higher NaCl, which retains the GNP color as red. This simple assay reaches the limit of detection of target miRNA‐195 as ∼40 fmol. Control experiments with noncomplementary DNA turned the solution into purple, indicating the specific detection of target. The mixture of target in diluted serum retains the color of the GNP solution to be red, indicating the selective detection of target DNA. This simple assay helps to quantify the level of miRNA‐195 target DNA and to diagnose the osteosarcoma.